ArticleWorld journal of clinical cases2024
Efficacy and safety of Nafamostat mesylate in patients with end-stage renal failure.
Kun Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it